{"version":"1.0","provider_name":"IMS Pharmastat Encyclop\u00e9die","provider_url":"https:\/\/www.ims-pharmastat.fr\/encyclopedie","title":"NNERF: Le Centre de R\u00e9f\u00e9rence National des Neuropathies Amylo\u00efdes Familiales et Autres Neuropathies P\u00e9riph\u00e9riques Rares","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"fRUYDSuDhv\"><a href=\"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/articles\/nnerf.html\">NNERF: Le Centre de R\u00e9f\u00e9rence National des Neuropathies Amylo\u00efdes Familiales et Autres Neuropathies P\u00e9riph\u00e9riques Rares<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.ims-pharmastat.fr\/encyclopedie\/articles\/nnerf.html\/embed#?secret=fRUYDSuDhv\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0NNERF: Le Centre de R\u00e9f\u00e9rence National des Neuropathies Amylo\u00efdes Familiales et Autres Neuropathies P\u00e9riph\u00e9riques Rares\u00a0\u00bb &#8212; IMS Pharmastat Encyclop\u00e9die\" data-secret=\"fRUYDSuDhv\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.ims-pharmastat.fr\/encyclopedie\/tube\/js\/wp-embed.min.js\n<\/script>\n","description":"Le Centre de R\u00e9f\u00e9rence des Neuropathies Amylo\u00efdes Familiales et Autres Neuropathies P\u00e9riph\u00e9riques Rares (NNERF) est le centre national labellis\u00e9 par le Minist\u00e8re de la Sant\u00e9 pour la prise en charge des neuropathies amylo\u00efdes familiales (NAF) et des neuropathies p\u00e9riph\u00e9riques rares en France. Coordonnateur historique : Pr David Adams, puis Dr Marie Th\u00e9audin, il est situ\u00e9 [&hellip;]"}